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Duodenal ulcer is the most common peptic ulcer disease worldwide. 
It is commoner than gastric ulcer.[1] It is not easy to distinguish 
between the two on the basis of the clinical presentation alone, so 
patients require upper gastrointestinal endoscopy to visualise and 
identify each ulcer. A decreasing prevalence of peptic ulcer disease 
has been observed in North America[2] and the Asia-Pacific region.[3] 
Several reasons have been suggested for this decline.
The actual prevalence of duodenal ulcer in the general population 
is difficult to determine, because upper gastrointestinal endoscopy 
is not routinely done for every patient with dyspepsia. Most patients 
who do not undergo endoscopy are aged <45 years, with previously 
uninvestigated and uncomplicated dyspepsia.[4] This age cut-off 
may vary between countries, depending on the prevalence of gastric 
cancer. Over-prescription and indiscriminate use of drugs such 
as antibiotics[5] and proton pump inhibitors[6] can also affect the 
prevalence of duodenal ulcer. Both drugs have activity against 
Helicobacter pylori, a major risk factor for peptic ulcer disease 
worldwide.[7] Their effects can be curative when both are used as 
part of triple or quadruple anti-Helicobacter therapy. However, they 
can lead to temporary resolution of ulcer symptoms even when they 
are not correctly used as part of such a regimen. They can also cause 
temporary suppression of the H. pylori activity in such cases.
Objective
To describe the changing endoscopic prevalence of duodenal ulcer 
between January 2000 and December 2010 at Obafemi Awolowo 
University Teaching Hospital (OAUTH), Ile-Ife, Nigeria.
Methods
This was a retrospective, descriptive study of patients who underwent 
upper gastrointestinal endoscopy at the endoscopy unit of OAUTH. 
The study data were retrieved from the endoscopy register, where 
the demographic data, indications for the procedure and endoscopic 
findings are recorded for all patients.
The study participants were all patients who underwent complete 
upper gastrointestinal endoscopy during the study period January 
2000 - December 2010. The data were collected per endoscopy 
and not per patient, i.e. the information was based on the number 
of procedures done over this time period and not the number of 
patients. This allowed for quick and easy data collection. (In the 
article, however, we refer to patients and give numbers of patients. 
Although the data were collected based on the number of procedures, 
so some patients may have had more than one procedure during 
the study period, we believe that the incomplete procedures and 
missing diagnoses that were excluded from the study probably negate 
the effect of data duplication and bring the situation closer to one 
patient = one procedure. We also believe that the large sample size 
makes any minimal data duplication insignificant with regard to the 
main outcome of the study.) All aborted procedures were excluded 
from the study, as the full extent of the diagnosis might not be known. 
They were mostly rescheduled for another time. This was helpful in 
limiting the duplication of data.
Variables analysed were demographic data (age and sex of patients), 
presenting symptoms (the indications for upper gastrointestinal 
endoscopy), and post-endoscopic diagnoses (the diagnoses made on 
the basis of the findings).
Procedure
All the patients fasted overnight before the procedure. They all 
consented to the procedure after full information had been provided 
to them. The procedure was done with the patient conscious and 
lying in the left lateral position.
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Background. Duodenal ulcer is the most common peptic ulcer disease worldwide. In the past, sub-Saharan Africa has been described as an 
area of mixed prevalence for peptic ulcer disease, but recent reports have disputed this. Changes in the prevalence of duodenal ulcer have 
been reported, with various reasons given for these.
Objective. To describe the change in endoscopic prevalence of duodenal ulcer at Obafemi Awolowo University Teaching Hospital 
(OAUTH), Ile-Ife, Nigeria, between January 2000 and December 2010.
Methods. This was a retrospective, descriptive study of patients who underwent upper gastrointestinal endoscopy in the endoscopy unit of 
OAUTH between January 2000 and December 2010. The data were obtained from the endoscopy register, demographic indices, presenting 
symptoms and post-endoscopic diagnoses being retrieved for each patient. The study period was divided into the years 2000 - 2004 and 
2005 - 2010, the frequencies of duodenal ulcer and other post-endoscopic diagnoses being compared between these two time periods to 
see whether there were changes.
Results. Over the study period, 292 patients (15.8%) were diagnosed with duodenal ulcer, second only to 471 patients (26.2%) with acute 
gastritis. The prevalence of duodenal ulcer for 2000 - 2004 was 22.9% (n=211 patients) compared with 9.2% (n=81) for 2005 - 2010 (p<0.001).
Conclusion. There was a significant decline in the endoscopic prevalence of duodenal ulcer over the decade.
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Topical pharyngeal anaesthesia was achieved with 10% xylocaine 
spray. This was followed by the intravenous injection of midazolam 
2.5 mg or diazepam 5 mg, depending on which was available at the 
time. The exceptions were individuals in whom sedatives/hypnotics 
were contraindicated. Patients were also given 20 mg hyoscine 
butylbromide intravenously before the start of the procedure.
Data collection
The data were collected between the years 2000 and 2010. Demographic 
data, presenting symptoms and post-endoscopic diagnoses, where 
available, were retrieved for each patient over this time period. The 
study period was divided into the years 2000 - 2004 and 2005 - 2010, 
and the variables were compared between these two periods to see 
whether there were changes in their frequency of occurrence between 
the first half of the study period and the latter half.
Statistical analysis
Data were analysed using the Statistical Package for the Social Sciences 
(SPSS), version 21.0 (IBM, USA). Medians and ranges were calculated 
for continuous variables, whereas proportions and frequency tables 
were used to summarise categorical variables. The Mann-Whitney 
U-test, a non-parametric test, was used to compare the median ages 
between the two study periods. The χ2 test and logistic regression 
analysis were used to test for significance of association between 
the independent (predictor) and dependent (outcome) variables for 
categorical variables. The level of significance was set at p<0.05.
Ethics and approval
All patients gave written informed consent for the procedure. Ethical 
clearance was obtained from the OAUTH Ethics and Research 
Committee (ref. no. IRB/IEC/0004553: NHREC/27/02/2009a).
Results
Demographic characteristics
A total of 1 937 patients underwent upper gastrointestinal endoscopy 
during the study period, of whom 138 were excluded owing to 
missing post-endoscopic diagnoses or incomplete procedures. A total 
of 1 799 patients were therefore included in the study, of whom 986 
were males (54.8%) and 813 females (45.2%). The ages of the patients 
ranged from 3 to 100 years (median 45). There was no significant 
difference in the sex distribution between the years 2000 - 2004 and 
2005 - 2010 (p=0.169) (Table 1). However, there was a significant 
difference in median ages between the years 2000 - 2004 and 2005 - 
2010 (p=0.044) (Table 1).
Presenting symptoms
Dyspepsia was the commonest indication for upper gastrointestinal 
endoscopy (Table 1). Of the patients, 1 335 (74.6%) presented with 
dyspepsia and 166 (9.2%) with upper gastrointestinal bleeding. There 
was a significant decline in the number of patients who underwent 
upper gastrointestinal endoscopy for investigation of dyspepsia in 
2005 - 2010 compared with 2000 - 2004 (p<0.001) (Table 1). The 
number of patients who underwent upper gastrointestinal endoscopy 
for investigation of upper gastrointestinal bleeding and suspected 
mitotic lesion increased significantly over the same time periods 
(p<0.001) (Table 1).
Post-endoscopic diagnoses
Duodenal ulcers were found in 292 patients (15.8%); this was second 
only to acute gastritis (n=471, 26.2%) (Table 2). Gastric ulcers were 
found in 237 patients (13.2%), while gastric erosions were seen in 
158 (8.8%).
The frequency of occurrence of duodenal ulcer in 2000 - 2004 was 
22.9% (n=211), compared with 9.2% (n=81) in 2005 - 2010 (p<0.001) 
(odds ratio 0.298, 95% confidence interval 0.222 - 0.400) (Table 3). 
There was a significant difference in the prevalence of duodenal ulcer 
between the two time periods, duodenal ulcer being 3.3 times less 
common in 2005 - 2010 compared with 2000 - 2004.
Discussion
The overall prevalence of duodenal ulcer in this study was 15.8% 
between 2000 and 2010. This is much lower than the 38.7% reported 
by Ndububa et al.[8] for the years 1992 - 1999. The two studies were 
done at the same institution but at different times. There was a 
significant decline in the prevalence of duodenal ulcer, from 22.9% 
in 2000 - 2004 to 9.2% in 2005 - 2010. Unexpectedly, the prevalence 
of gastric ulcer, a peptic ulcer disease like duodenal ulcer, did not fall 
over the same study periods.
The trend of a decline in duodenal ulcer prevalence has also 
been reported by other studies in Nigeria,[9] North America[2] and 
the Asia-Pacific region.[3] It is therefore not unique to our centre. 
The significant decline in the number of patients who underwent 
Table 1. Comparison of age, sex and presenting symptoms of patients undergoing upper gastrointestinal endoscopy between 
2000 - 2004 and 2005 - 2010
Variables
2000 - 2004
(N=921)
2005 - 2010
(N=878)
2000 - 2010
(N=1 799) p-value
Sex, n (%)  0.169
Male 490 (53.2) 496 (56.5) 986 (54.8)
Female 431 (46.8) 382 (43.5) 813 (45.2)
Age (yr), median 45 46.5 45 0.044*
Presenting symptom, n (%)
Dyspepsia 733 (79.6) 602 (68.6) 1 335 (74.6) <0.001
Gastrointestinal bleeding 58 (6.3) 108 (12.3) 166 (9.2) <0.001
Suspected mitotic lesion 53 (5.8) 95 (10.8) 148 (8.2) <0.001
Gastric outlet obstruction 39 (4.2) 36 (4.1) 75 (4.2) 0.907
Liver cirrhosis 20 (2.2) 9 (1.0) 29 (1.6) 0.061
Foreign body 4 (0.4) 2 (0.2) 6 (0.3) 0.688
Other† 10 (1.1) 16 (1.8) 26 (1.4) 0.236
*Mann-Whitney U-test.
†Suspected achalasia, motility disorders.
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upper gastrointestinal endoscopy to investigate dyspepsia over 
the study period further supports a true decline in the prevalence 
of duodenal ulcer. Several reasons were given for this decline in 
North America and the Asia-Pacific region. They were a reduced 
prevalence of H. pylori infection, improved hygiene and improved 
eradication of H. pylori.[2,3] This is not the case in Nigeria, where 
the incidence of H. pylori infection is still very high.[10]
Overprescription and widespread use of drugs such as antibiotics[5] 
and proton pump inhibitors [6] could also be responsible for the 
decline in duodenal ulcer prevalence. H. pylori is a major risk factor 
for duodenal ulcer.[7] It is responsive to both proton pump inhibitors 
and antibiotics, either partially or completely. Increased use of 
proton pump inhibitors and antibiotics, albeit for other reasons, 
could therefore suppress this organism and encourage temporary 
healing and resolution of the symptoms of duodenal ulcer. There is 
widespread indiscriminate use of antibiotics in Nigeria.[5] We did not 
document the overuse of proton pump inhibitors in our patients, 
our study being a retrospective one; in fact, there are currently no 
Nigerian studies documenting this. However, overuse of these drugs, 
which have anti-H. pylori and mucosal healing properties, has been 
documented in other parts of the world.[6] The personal experience 
of the first author (OI) is that proton pump inhibitors are widely 
used by patients who come to our centre complaining of dyspepsia. 
Patients are likely to have used both proton pump inhibitors and 
antibiotics before they undergo upper gastrointestinal endoscopy, 
which is usually performed because these empirical treatments have 
failed. However, the above reason does not explain the non-decline 
of gastric ulcer prevalence in this study. H. pylori is also a causal 
agent for gastric ulcer.[7] The widespread use of antibiotics and proton 
pump inhibitors should also affect the prevalence of gastric ulcer 
and cause a decline like that of duodenal ulcer, but the prevalence 
of gastric ulcer was steady over the study period. There was even 
a rise in prevalence compared with the study done by Ndububa et 
al.,[8] from 4.7% in 1992 - 1999[8] to 13.2% for our study period 2000 - 
2010. Even the prevalence of gastric erosions, which should also be 
affected by the overuse of proton pump inhibitors, increased – from 
2.9%[8] to 8.8% in our study. The reasons for the above anomaly are 
not very clear, considering the decline in the prevalence of duodenal 
ulcer over the same periods. However, it could be due to the increased 
use of aspirin and non-steroidal anti-inflammatory drugs in Nigeria 
over the past two decades.[11] These drugs are prominent causes of 
gastric ulcers and erosions, and can also cause upper gastrointestinal 
bleeding. The increased incidence of upper gastrointestinal bleeding 
in our study could also be due to increased use of aspirin and non-
steroidal anti-inflammatory drugs in Nigeria.
Other factors that may be responsible for the decline in the 
prevalence of duodenal ulcer over the study period should be 
considered because of the unexpected difference in the changing 
prevalence patterns of duodenal ulcer and gastric ulcer. One of 
these is the expertise of the endoscopist – his or her ability to 
achieve duodenal intubation and to recognise gastrointestinal lesions, 
including duodenal ulcer. Several endoscopists did the endoscopies in 
our study, from both the surgical and medical specialties. They had 
differing levels of competence. Whether this variation in competence 
is sufficient to affect the apparent prevalence of duodenal ulcer is a 
question that is difficult to answer. Auditing the upper gastrointestinal 
endoscopic procedures done by each individual endoscopist would 
show each one’s contribution to the prevalence of duodenal ulcer 
over the study period. Only then would we know whether levels of 
competence in fact played a major role.
Table 2. Post-endoscopic diagnoses (N=1 799)
Variables Patients, n (%)*
Acute gastritis 471 (26.2)
Duodenal ulcer 292 (15.8)
Gastric ulcer 237 (13.2)
Atrophic gastritis 188 (10.5)
GORD 176 (9.8)
Gastric erosion 158 (8.8)
Normal endoscopic finding 155 (8.6)
Gastric tumour 100 (5.6)
Oesophageal varices 79 (4.4)
Gastric polyp 20 (1.1)
Duodenal polyp 12 (0.7)
Oesophageal tumour 13 (0.7)
Early gastric cancer 26 (1.4)
Other† 69 (3.8)
GORD = gastro-oesophageal reflux disease.
*Some patients had multiple pathologies, so the post-endoscopic diagnoses outnumber 
the total number of patients and the percentages total more than 100%.
†Oesophageal stricture/ulcers/erosions, achalasia, foreign-body ingestion, external 
compression of the stomach/duodenum.
Table 3. Comparison of prevalences of post-endoscopic diagnoses between 2000 - 2004 and 2005 - 2010
Diagnosis
2000 - 2004* 
(N=921),
n (%)†
2005 - 2010 
(N=878),
n (%)† B p-value OR 95% CI
Duodenal ulcer 211 (22.9) 81 (9.2) –1.211 <0.001 0.298 0.222 - 0.400
Gastric ulcer 117 (12.7) 120 (13.7) –0.140 0.352 0.870 0.648 - 1.167
Acute gastritis 249 (27.0) 222 (25.3) –0.304 0.010 0.738 0.586 - 0.929
Atrophic gastritis 93 (10.1) 95 (10.8) –0.158 0.333 0.854 0.620 - 1.175
GORD 90 (9.8) 86 (9.8) –0.212 0.202 0.809 0.585 - 1.120
Gastric erosion 79 (8.6) 79 (9.0) –0.065 0.708 0.937 0.668 - 1.315
Oesophageal varices 29 (3.1) 50 (5.7) 0.287 0.242 1.332 0.823 - 2.156
Gastric tumour 61 (6.6) 39 (4.4) –0.683 0.002 0.505 0.330- 0.774
Oesophageal tumour 10 (1.1) 3 (0.3) –1.446 0.029 0.235 0.064 - 0.863
Gastric polyp 11 (1.2) 9 (1) –0.251 0.586 0.778 0.315 - 1.922
Duodenal polyp 3 (0.3) 9 (1) 0.859 0.201 2.361 0.633 - 8.807
GORD = gastro-oesophageal reflux disease; B = beta coefficient; OR = odds ratio; CI = confidence interval.
*2000 - 2004 is the reference category for the dependent variable. Negative post-endoscopic diagnoses are the reference categories for each of the independent variables.
†Some patients had multiple pathologies, so the post-endoscopic diagnoses outnumber the total number of patients and the percentages total more than 100%.
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Our hospital is a tertiary institution and referral centre, and we 
probably do not see many uncomplicated cases of peptic ulcer 
disease. These patients are likely to consult their primary care 
physicians because of ease of access, and will only be referred if 
they develop complications. This apparent reduction in the burden 
of duodenal ulcer could be misinterpreted as a reduction in its 
prevalence. There was an increase in the number of patients who 
underwent upper gastrointestinal endoscopy in our study (N=1 799) 
compared with the study by Ndububa et al.[8] in the same endoscopy 
unit (N=834). However, this did not translate into an increased 
prevalence of duodenal ulcer – instead, there was a decrease in 
prevalence over the two decades. The reduction in duodenal ulcer 
prevalence was therefore not due to a reduced number of endoscopic 
referrals, as the reverse is the case. Instead it may be due to the choice 
of patients being referred, as explained above. However, referral bias 
may not have as much effect as would be expected, because most 
endoscopies are done in tertiary institutions like ours. Our results 
were based mainly on endoscopic diagnoses of duodenal ulcer, and 
not symptomatic diagnoses. Furthermore, referral bias does not 
explain why the prevalence of duodenal ulcer decreased, while that 
of gastric ulcer did not.
Upper gastrointestinal endoscopy is not routinely done for 
patients with dyspepsia, especially those aged <45 years,[4] despite 
dyspepsia being a major symptom of peptic ulcer disease (the 
exceptions being patients with symptoms or signs that may suggest 
gastrointestinal bleeding, gastrointestinal malignancy or gastric 
outlet obstruction). [12] This is because the risk of gastric cancer is low 
in this age group and most of these patients have negative endoscopic 
findings. This is intended as a cost-saving measure, and a means of 
avoiding the possible complications of endoscopy. However, it would 
prevent the actual prevalence of duodenal ulcer from being known, 
especially in patients aged <45, as it would lead to a falsely reduced 
endoscopic prevalence of duodenal ulcer. Most patients aged <45 are 
treated empirically or on the basis of non-invasive tests for H. pylori 
such as a urea breath test and a stool antigen test. However, this also 
does not explain the difference in prevalence between gastric and 
duodenal ulcer.
Study limitations
A limitation of the study is that it is retrospective. The information 
was collected from a joint surgical and medical endoscopy register, 
and there was no way to obtain more than what was recorded there. 
Furthermore, there was no way to go back and review the diagnoses, 
as they were based on a one-time-look procedure by the endoscopist.
Another important limitation of this study is that the patients 
whose records were analysed may not be representative of the 
general population, because it was a hospital-based study and not a 
community-based one.
A further limitation is that the data were collected on a per 
endoscopy basis and not per patient. This would have led to 
duplication of some data and could have affected the validity of the 
results. However, it is difficult to ascertain the magnitude of this 
effect, and whether it would have led to an increase or a decrease in 
the endoscopic prevalence of duodenal ulcer.
Conclusion
This study showed a decline in the endoscopic prevalence of 
duodenal ulcer over the decade 2000 - 2010 in our institution. The 
significant reduction in the number of patients who underwent upper 
gastrointestinal endoscopy to investigate dyspepsia over the study 
period further supports a true decline in the prevalence of duodenal 
ulcer. The reasons for this decline are not entirely clear, although 
several have been considered. These include widespread use of 
proton pump inhibitors and antibiotics by patients before endoscopy, 
differing competences of the endoscopists who contributed to the 
endoscopic data, non-referral of many uncomplicated cases of 
dyspepsia to our tertiary institution, and the general rule of not 
routinely doing upper gastrointestinal endoscopy for patients with 
uncomplicated dyspepsia, especially those aged <45 years.
Studies done in North America and the Asia-Pacific region 
have attributed this decline to increased eradication and a reduced 
prevalence of H. pylori infection.[2,3] Although studies in Nigeria have 
shown that the prevalence of H. pylori is still high,[10] we recommend 
that future research includes the H. pylori status of patients. This 
will help to ascertain whether a reduction in H. pylori prevalence is 
also responsible for the decline in duodenal ulcer prevalence in our 
environment.
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